The global boom in GLP-1 receptor agonists, led by Wegovy and Mounjaro, is driving exceptional growth in European e-pharmacy and community pharmacy. While digital sales set new records, pharmaceutical logistics faces an unprecedented stress test.
Businesses that store, pick or ship high-value products such as Wegovy and Mounjaro at scale operate between commercial opportunity and stringent GDP obligations. A failure to control temperature-sensitive processes may jeopardise product quality and regulatory compliance.
tiger.PHARMA provides a data-led platform for managing these product volumes in both the B2B pharmaceutical market and direct patient delivery.
The dual challenge: from the B2B hub to the patient’s door
Traditional pharmaceutical wholesale often divides portfolios rigidly into “refrigerated” and “ambient” products. At the volumes generated by Wegovy and Mounjaro, this broad classification creates inefficiency at both stages of the supply chain:
- B2B pharmaceutical market: cold rooms in logistics hubs and interim warehouses reach capacity. Without precise control of which PZN genuinely requires which storage space and temperature corridor, companies waste qualified capacity and restrict throughput.
- B2C patient delivery: without granular data, last-mile systems may over-engineer packaging. If a GLP-1 pen is ordered with non-critical products, the whole parcel may be placed in an expensive insulated shipper, eroding e-commerce margin.
The tiger.PHARMA approach: temperature-led PZN clustering
We replace the old binary model with a differentiated approach. The protected tempdata.TIGER stability database and data-driven temperature clustering allocate the portfolio to five precise logistics corridors.
B2B infrastructure optimisation
For hospital suppliers, manufacturers, wholesalers and pharmacy groups, we optimise logistical provisioning. Integrated tools such as MSV3.tiger connect pharmacy order intake with manufacturer-validated stability windows for more than 738,000 products. This allows high-value medicines to be stored and moved using product-level evidence rather than broad safety assumptions.
B2C fulfilment support for online pharmacies
Mail-order pharmacies supplying Wegovy or Mounjaro directly to patients can use dynamic packing logic. Mixed customer orders are divided by volume and temperature need. Cold-chain products are isolated appropriately, while suitable accompanying products remain in cost-efficient standard packaging.
Evidence-based assessment of delayed returns
If a patient parcel is delayed in the carrier network, an MKT-based risk assessment using mean kinetic temperature can support a documented evaluation of whether biochemical stability has been maintained.
Cross-border expertise and GxP assurance
Technology is only half the solution. The advantage lies in combining data assets with practical pharmaceutical and regulatory knowledge for B2B and B2C structures.
Large European online pharmacies increasingly manage high-volume operations through cross-border hubs, including locations in western Czechia. tiger.PHARMA supports the interface between Czech export requirements, the expectations of SÚKL and the transport-validation standards applied by German pharmacy and medicines authorities.
GLP-1 growth requires rigorous data
The market for obesity and diabetes therapies will continue to grow. The winners will be businesses with the most resilient, data-led and GxP-compliant supply chains, from manufacturer goods receipt to patient handover. Temperature clustering can reduce packaging costs, increase throughput and support GDP compliance across the pharmaceutical market.
Would you like to connect B2B order intake or pharmacy fulfilment with the intelligent PZN clustering of tempdata.TIGER?
Contact the tiger.PHARMA GDP specialists at 247@tiger-pharma.com.